Registered doctors who make health content now ask the same question: can I take money from a brand to talk about its product? For most commercial arrangements under the National Medical Commission's October 2026 notice, the answer is no, and the exceptions are narrower than many agencies assume.
This post is for doctors who publish on Instagram, YouTube or LinkedIn, and for the hospital and brand teams that approach them. It reads the NMC notice on ethical advertising and public communication, sets out which paid arrangements it appears to prevent and which it leaves room for, and suggests contract and disclosure structures to take to a lawyer.
A caution applies throughout. The sources below include a trade summary of the notice and the NMC's own document. Read the clause wording yourself and take legal advice before signing. This post explains a regulation. It does not replace advice on your registration.
What the notice is
The Ethics and Medical Registration Board of the NMC issued a public notice on 6 October 2026. Medical Dialogues summarises it, and the notice is published on the NMC website. According to that summary, it takes effect immediately, applies to registered medical practitioners (RMPs) and clinical establishments, and exempts government programme campaigns. Penalties for practitioners are graded, from a warning and ethics training for a first violation to removal from the register for repeated violations. A practitioner who personally authorised a prohibited communication may be reviewed separately.
Our compliance handbook covers the whole notice. This post stays with the creator question.
The provisions that decide paid partnerships
The summary lists several restrictions that bear directly on influencer work. Quoting clause letters from a secondary source is risky, so check each against the notice.
- No use of name, image, voice, testimonial or endorsement to promote services or products. RMPs may not permit this. That is the central restriction on a paid brand deal.
- No endorsement of a drug, device or health product for advertising. No approval, recommendation or statement about such a product for advertising, directly or indirectly.
- No third party doing it for you. RMPs may not use or permit a celebrity, influencer, patient, employee or other third party to do what the RMP cannot do directly. A doctor cannot route an endorsement through an agency or a family member's account.
- No commissions or referral-linked payments. No commissions, rebates, bonuses, gifts, referral fees or lead-generation fees linked to patient referral.
- No payment tied to procuring patients. Agency, influencer or platform arrangements cannot link payment to procuring or referring individual patients.
- No fake engagement. Manipulating followers, likes, reviews, ratings or search rankings is prohibited.
- No synthetic endorsements. AI cannot be used to produce an endorsement or testimonial from a real patient, practitioner or other person, and AI-generated promotional content must be marked as such.
- Material commercial relationships must be disclosed in lawful public-health or informational communication.
The last item is the one that creates room for manoeuvre.
Reading the sponsored-content question
Put the provisions together and three categories emerge.
Prohibited in practice: paying the doctor to promote a product or service
If a company pays you, or gives you something of value, and the output is a post or video in which you praise or recommend its drug, device, supplement, app, clinic, or hospital, it is the kind of arrangement the notice targets. Adding a "#ad" label does not turn it into something else. Disclosure is a requirement for permitted communication. It does not authorise a prohibited one.
This covers the common pattern: a skincare brand pays a dermatologist for a reel recommending a product, a device company pays a surgeon to demonstrate it, a health app pays a doctor to endorse it.
Unclear: paid educational or public-health content
The notice speaks of lawful public-health or informational communication and requires disclosure of any material commercial relationship. That implies some sponsored informational content can exist. The boundary question is whether the content endorses anything.
A sponsored series on, say, recognising the symptoms of a common condition, with no product mention and a plain "supported by" statement, is a different thing from a video reviewing a brand's device. But a sponsor's name on an educational piece can still look like an endorsement of the sponsor, and a regulator may read it that way. If in doubt, ask the NMC or your state medical council in writing, and keep the reply.
Probably outside the notice: your own non-promotional content
Posting educational material on your own, unpaid, with no commercial relationship, falls under general professional conduct and the earlier advertising limits. It is not a "paid partnership" at all. Our explainer on what Indian doctors may say online covers the general limits.
Honoraria: what the notice does and does not say
Doctors often ask about honoraria. The summary reports that the notice does not use the word. It does bar commissions, rebates, bonuses, gifts, gratuities, referral fees and lead-generation fees linked to patient referral.
So the useful test is not what the payment is called but what it is for. Payment for a genuine professional service, such as a faculty fee for a continuing medical education session where you teach clinical content, is a different thing from payment for your face on a brand's channel. Whether a specific honorarium is acceptable depends on the nature of the service, the payer and other rules that apply to you. Pharmaceutical company payments to practitioners are also governed by the pharma marketing code, UCPMP 2024, and by your employer's policies. Do not assume that a fee that is acceptable for a conference talk is acceptable for a social post.




